Intraosseous transfusion with liposome-encapsulated hemoglobin improves mouse survival after hypohemoglobinemic shock without scavenging nitric oxide

Shock

Volumn 35, Issue 1, 2011, Pages 45-52

  Shono, Satoshi ^a   Kinoshita, Manabu ^a   Takase, Bonpei ^a   Nogami, Yashiro ^a   Kaneda, Shinichi ^b   Ishihara, Masayuki ^c   Saitoh, Daizoh ^a   Kikuchi, Makoto ^a   Seki, Shuhji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Terumo Research Institute   (Japan)

^c Divisions of Biomedical Engineering   (Japan)

Author keywords

Blood substitute; erythropoietin; hemodilution; hemorrhage; NO2 j; NO3 j; resuscitation; TNF

Indexed keywords

ALBUMIN; HEMOGLOBIN; LIPOSOME ENCAPSULATED HEMOGLOBIN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CATHETER; CIRCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMUR; FLUID RESUSCITATION; HEMATOLOGIC DISEASE; HEMODILUTION; HEMORRHAGIC SHOCK; HUMAN; HYPOHEMOGLOBINEMIC SHOCK; MALE; MOUSE; NONHUMAN; RESUSCITATION; SURVIVAL;

ANIMALS; BLOOD COMPONENT TRANSFUSION; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; LIPOSOMES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; SHOCK, HEMORRHAGIC;

EID: 78650777425     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181e46e93     Document Type: Article

References (26)

1. Manning JE, Katz LM, Brownstein MR, Pearce LB, Gawryl MS, Baker CC: Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina resuscitation research group. Shock 13:152-159, 2000.
2. Squires JE: Artificial blood. Science 295:1002-1005, 2002.
3. Johnson T, Arnaud F, Dong F, Philbin N, Rice J, Asher L, Arrisueno M, Warndorf M, Gurney J, McGwin G, et al.: Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuationVeffects on histopathology and organ function. Crit Care Med 34:1464-1474, 2006.
4. Kasper SM, Walter M, Grune F, Bischoff A, Erasmi H, Buzello W: Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 83:921-927, 1996.
5. Schubert A, O'Hara JF Jr, Przybelski RJ, Tetzlaff JE, Marks KE, Mascha E, Novick AC: Effect of diaspirin crosslinked hemoglobin (DCLHb HemAssist) during high blood loss surgery on selected indices of organ function. Artif Cells Blood Substit Immobil Biotechnol 30:259-283, 2002.
6. Kerner T, Ahlers O, Veit S, Riou B, Saunders M, Pison U: DCL-Hb for trauma patients with severe hemorrhagic shock: the European Bon-scene[ multicenter study. Intensive Care Med 29:378-385, 2003.
7. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM: Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 299:2304-2312, 2008.
8. Stern S, Rice J, Philbin N, McGwin G, Arnaud F, Johnson T, Flournoy WS, Ahlers S, Pearce LB, McCarron R, et al.: Resuscitation with the hemoglobin-based oxygen carrier, HBOC-201, in a swine model of severe uncontrolled hemorrhage and traumatic brain injury. Shock 31:64-79, 2009.
9. Ogata Y, Goto H, Kimura T, Fukui H: Development of neo red cells (NRC) with the enzymatic reduction S-stem of methemoglobin. Artif Cells Blood Substit Immobil Biotechnol 25:417-427, 1997.
10. Kaneda S, Ishizuka T, Goto H, Kimura T, Inaba K, Kasukawa H: Liposome-encapsulated hemoglobin, trm-645: current status of the development and important issues for clinical application. Artif Organs 33:146-152, 2009.
11. Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E: Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions. J Intern Med 263:4-15, 2008.
12. Nogami Y, Kinoshita M, Takase B, Ogata Y, Saitoh D, Kikuchi M, Ishihara M, Maehara T: Liposome-encapsulated hemoglobin transfusion rescues rats undergoing progressive hemodilution from lethal organ hypoxia without scavenging nitric oxide. Ann Surg 248:310-319, 2008.
13. Drinker C, Drinker K, Lund C: The circulation in the mammalian bone marrow. Am J Physiol 62:1-92, 1922.
14. Henning N: Intrasternal injections and transfusion. JAMA 128:240, 1945.
15. Dubick MA, Holcomb JB: A review of intraosseous vascular access: current status and military application. Mil Med 165:552-559, 2000.
16. Sakai H, Masada Y, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E: Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 32:539-545, 2004.
17. Tait AR, Larson LO: Resuscitation fluids for the treatment of hemorrhagic shock in dogs: effects on myocardial blood flow and oxygen transport. Crit Care Med 19:1561-1565, 1991.
18. Martini J, Carpentier B, Negrete AC, Frangos JA, Intaglietta M: Paradoxical hypotension following increased hematocrit and blood viscosity. Am J Physiol Heart Circ Physiol 289:H2136YH2143, 2005.
19. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG: Regulation of endothelial cell nitric oxide S-nthase mRNA expression by shear stress. Am J Physiol 269:C1371-C1378, 1995.
20. Dimmeler S, Zeiher AM: Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87:434-439, 2000.
21. 51Cr-labeled autologous red blood cells. J Trauma 31:1487-1489, 1991.
22. Neufeld JD, Marx JA, Moore EE, Light AI: Comparison of intraosseous, central, and peripheral routes of crystalloid infusion for resuscitation of hemor-rhagic shock in a swine model. J Trauma 34:422-428, 1993.
23. Schoffstall JM, Spivey WH, Davidheiser S, Lathers CM: Intraosseous crystalloid and blood infusion in a swine model. J Trauma 29:384-387, 1989.
24. Levien LJ. South Africa: clinical experience with Hemopure. ISBT Sci Ser 1:167-173, 2006.
25. Tsutsui Y, Kimura T, Ishizuka T, Oomori S, Shizawa T, Goto H, Ogata Y, Kaneda S: Duration of efficacy of NRC (neo red cell) in a rat hemodilution model [in Japanese]. Artif Blood 10:36-41, 2002.
26. Tsutsui Y, Ishizuka T, Goto H, Kimura T, Ogata Y, Kaneda S: Duration of efficacy of NRC (neo red cell) administered in divided doses [in Japanese]. Artif Blood 11:200-204, 2003.